PATENT CLAIM ANALYSIS

Application Number: 15969350
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "277000"]

Abstract:
Within the scope of the present invention is a new pharmacological strategy for the treatment of tumors based on anti-tumoral immune responses.

Claim (Index 4):
The method of  claim 3 , wherein the ion-channel modulator is BAY K8644.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.15
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14350588', '14955539', '14021353', '15855507', '14158531']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7323536031575894
- 35 USC 102 Novelty (BERT): 0.5153642050638206
- Combined Prediction Score: 0.7106546633482125
- Mean Citation Score: 223.227128
- Max Citation Score: 224.82881
- Similarity Product: 136.6695258278954

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test